Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.23B
Enterprise Value6.59B
P/E Ratio-76.86
PEG Ratio0.57
Price/Sales Ratio1.27
Price/Book Ratio2.96
Enterprise/Revenue1.67
Enterprise/EBITDA62.81

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.02
Operating Margin-0.01
AD

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.04

Income Statement

Revenue2.71B
Revenue/Share10.36
Gross Profit943.63M
EBITDA149.36M
Net Income-98.33M
Diluted EPS-0.34

Balance Sheet

Total Cash227.72M
Total Cash/Share0.8
Total Debt1.43B
Total Debt/Equity1.13
Current Ratio0.98
Book Value Per Share5.85

Price History

52-Week Change-45.21
52-Week High32.27
52-Week Low12.27
Moving Average 50 Days14.49
Moving Average 200 Days18.13

Statistics

Average Volume11.83M
Shares Outstanding285.46M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.07
Trailing Annual Dividend Yield0.53
Payout Ratio-1.69
Last Split Factor13:10
Last Split DateMay 19, 2017
AD